Posted in | News | Nanoanalysis

Nanomaterials Characterization Challenges to be Presented by Head of Product Management at Malvern Instruments

Ciaran Murphy, Head of Product Management at Malvern Panalytical, will present ‘Nanomaterials Characterization Challenges’, discussing the high resolution analytical techniques available to assess the impact of nanomaterials when released into the environment.

The presentation on 9 April 2014 will form part of Nanomaterials in Medicine and the Environment session at the Nanomaterials for Industry conference, from April 6 – 9, in San Diego, California. The conference aims to provide insight for scientists, engineers and business leaders on the rapidly expanding technology and applications of nanomaterials. See www.bit.ly/MALNI for further information.

In his conference presentation Ciaran Murphy will discuss how the current EU definition of nanomaterials is driving the need for higher resolution measurement capabilities. He will review some of the latest development activity using light scattering techniques and separations devices aimed at addressing the requirements for number-based (quantitative) measurement on nanomaterials. The work described focuses on the characterization of metallic nanoparticles (silver, gold) and how separation devices such as FFF and Fluidics can be combined with detectors to offer an improvement in the resolution currently available and in line with the demands of the EU nanomaterials definition.

Various nanoparticle parameters are of importance when assessing the potential toxicological impact of nanoparticles in the environment. Malvern Panalytical’s analytical solutions for nanoscale characterization encompass an expanding range of different technologies. Used individually or in combination these provide access to many different parameters to suit both the assessment of nanoparticles’ potential toxicity and a wide variety of measurement applications.

Zetasizer Nano instruments use light scattering techniques to measure intensity weighted particle size, zeta potential, protein charge and molecular weight. NanoSight Nanoparticle Tracking Analysis (NTA) detects and visualizes populations of nanoparticles, determining concentration and measuring the size of each particle from direct observations of diffusion. Archimedes employs the technique of resonant mass measurement to provide particle counting capability, as well as high resolution size determination on small quantities of sample.

For details of the Nanomaterials for Industry conference, visit www.bit.ly/MALNI

To find out about Malvern Panalytical’s analytical solutions for characterization at the nanoscale visit

http://www.malvern.com/nanoparticles.

Malvern Panalytical, Malvern Panalytical, Zetasizer and NanoSight are registered trademarks of Malvern Panalytical.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Malvern Panalytical. (2019, February 11). Nanomaterials Characterization Challenges to be Presented by Head of Product Management at Malvern Instruments. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=29701.

  • MLA

    Malvern Panalytical. "Nanomaterials Characterization Challenges to be Presented by Head of Product Management at Malvern Instruments". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=29701>.

  • Chicago

    Malvern Panalytical. "Nanomaterials Characterization Challenges to be Presented by Head of Product Management at Malvern Instruments". AZoNano. https://www.azonano.com/news.aspx?newsID=29701. (accessed November 21, 2024).

  • Harvard

    Malvern Panalytical. 2019. Nanomaterials Characterization Challenges to be Presented by Head of Product Management at Malvern Instruments. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=29701.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.